4th Quarter - Termination
ARNALL GOLDEN GREGORY, LLP for PHARMA AND BIOPHARMA OUTSOURCING ASSOCIATION
Income
—
Expenses
—
Terminated
Oct 10, 2016
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
FDA issues; Generic Drug Free User Act issues; small business relief legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN PARVER | — |
| JOE RUBIN | — |
| LEAH MENDELSOHN STONE | — |
Medical/Disease Research/Clinical Labs MED
FDA oversight issues of generic drugs; issues regarding generic drug user fees; 21st Century CURES Act; Innovation for Healthier Americans Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALAN PARVER | — |
| JOE RUBIN | — |
| LEAH MENDELSOHN STONE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.